Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells

Sandrine Valsesia-Wittmann1, Maud Magdeleine, Sébastien Dupasquier

  • 1INSERM U590, Centre Léon Bérard, Université Claude Bernard Lyon 1, Lyon F-69008 France.

Cancer Cell
|December 21, 2004
PubMed

Insights

N-Myc amplification in neuroblastoma drives cancer growth. Overexpressed Twist inhibits the ARF/p53 pathway, cooperating with N-Myc to promote cell transformation and malignant outgrowth, bypassing apoptosis safeguards.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • N-Myc oncogene amplification is common in neuroblastoma, correlating with poor prognosis.
  • N-Myc activation promotes cell proliferation and apoptosis, but p53 mutations are rare in neuroblastoma.
  • This suggests an alternative mechanism circumvents p53-mediated apoptosis in N-Myc-driven neuroblastoma.

Purpose of the Study:

  • To investigate cooperating genetic events in N-Myc-amplified neuroblastomas.
  • To identify factors that circumvent the ARF/p53 pathway in this cancer.
  • To understand the oncogenic cooperation between N-Myc and other regulatory genes.

Main Methods:

  • Pangenomic cDNA microarray analysis was performed on neuroblastoma samples.
  • Expression levels of human Twist (H-Twist) were assessed in relation to N-Myc amplification.
  • The impact of H-Twist overexpression on the ARF/p53 pathway was investigated.

Main Results:

  • Human Twist (H-Twist) is consistently overexpressed in N-Myc-amplified neuroblastomas.
  • H-Twist overexpression inhibits the ARF/p53 pathway.
  • This inhibition bypasses the apoptotic response typically triggered by Myc activation.

Conclusions:

  • Overexpression of Twist cooperates with N-Myc in neuroblastoma pathogenesis.
  • The Twist/ARF/p53 axis is a critical pathway in N-Myc-driven oncogenesis.
  • This oncogenic cooperation between N-Myc and Twist leads to cell transformation and tumor growth.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...